✦ LIBER ✦

Biopharmaceutical and chemical firms’ R&D disclosure, and cost of equity: The impact of the regulatory regime

✍ Scribed by La Rosa, Fabio; Liberatore, Giovanni

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Disclosure and the cost of equity in int

✍ Tim V. Eaton; John R. Nofsinger; Daniel G. Weaver 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 308 KB

The Impact of Better Corporate Social Re

✍ Carmelo Reverte 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

The Impact of Consumer Attentiveness and

✍ Ghosh, Bikram; Galbreth, Michael R. 📂 Article 📅 2013 🏛 INFORMS 🌐 English ⚖ 369 KB

The cost of biopharmaceutical R&D: is bi

✍ Joseph A. DiMasi; Henry G. Grabowski 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

The impact of cross-border mergers and a

✍ Stiebale, Joel 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 436 KB

Evidence on the impact of R&D and ICT in

✍ Hall, Bronwyn H.; Lotti, Francesca; Mairesse, Jacques 📂 Article 📅 2013 🏛 Taylor and Francis Group 🌐 English ⚖ 331 KB